Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.42 EUR | -1.27% | -2.66% | +26.48% |
20/05 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
08/05 | Abivax: four abstracts to be presented on obefazimod | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.48% | 86Cr | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax Names New Chief Medical Officer